Boundless Bio, Inc.
USD2.45
-0.11 (-4.30%)
CEO
Zachary Hornby
IPO Date
2016-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.55
Prev. Close
$2.56
Day Low
$2.41
Day High
$2.58
52W Low
$0.96
52W High
$2.79
Market Cap
$0.06B
Volume
0.29M
| 48,000 |
| $1.40 |
| 15 Jun 2026 | Christensen James | director | A-Award | Acquired | 32,000 | $1.40 |
| 15 Jun 2026 | Lew Jennifer | director | A-Award | Acquired | 32,000 | $1.40 |
| 26 Jan 2026 | Oien Jessica | See Remarks | A-Award | Acquired | 220,000 | $1.26 |
| 26 Jan 2026 | Hassig Christian | Chief Scientific Officer | A-Award | Acquired | 230,000 | $1.26 |
| 26 Jan 2026 | Doebele Robert | Chief Medical Officer | A-Award | Acquired | 230,000 | $1.26 |
| 26 Jan 2026 | Hornby Zachary | director, officer: President & CEO | A-Award | Acquired | 600,000 | $1.26 |
| 26 Jan 2026 | HINKLE DAVID A | See Remarks | A-Award | Acquired | 140,000 | $1.26 |
| 23 Jun 2025 | Brennan Christine | director | A-Award | Acquired | 16,000 | $1.03 |